| Doctor Profile |
Summaries of Clinical Studies on the Oral Chelation and Age-Less Formula
Most Companies Do Not Have Their Own Clinical Studies Using Their Own Formula, WE DO!
Below you will find summaries of two separate studies on humans that verify Extreme Health's Oral Chelation/Age-Less Formula's positive results. A third summary is being completed now with even more impressive results!Click here to go to the First Clinical Studies
Click here to go to the Second Clinical Studies
Click here to see a listing of other studies available upon request
Numerous studies citing the powerful effects of any chelating formula are included below Extreme Health's studies.
Summaries of the First Clinical Studies on the Oral Chelation and Age-Less Formula
Note: Copies of the full studies are available upon request.
- In 1998, Extreme Health conducted heavy metal urine analyses on 14 patients, ages ranging from 29 to 68 and from a variety of different occupations, before and after only one day's dose of the Oral Chelation and Age-Less formulas. Omegatech, King James Medical Laboratory, Inc., in Cleveland, Ohio, analyzed the urine samples.
The results showed significant excretion of all six of the heavy metals most commonly encountered and damaging to health. The following are the average percentages of increase in the 14 patients' heavy metal excretions after just one day on the formulas:
Aluminum: 229%
Arsenic: 661%
Cadmium: 276%
Lead: 350%
Mercury: 773%
Nickel: 9,439%
- Hair analyses. Great Smokie's Diagnostic Laboratory tested two patients before oral chelation and after six months on the program. Both tested significantly lower for toxic heavy metals. In one case, a dentist who had high exposure to mercury, the second hair analysis showed a decrease or a normal reading in all heavy metals that were abnormally high on the first hair analysis, except for mercury which was higher. In the other case, a dentist hygienist, the second hair analysis showed a decrease or a normal reading in all heavy metals that were abnormally high on the first analysis, except for silver which went higher.
Heavy metals can be stored deep in the tissues, brain, and nerve ganglion. When all heavy metals except one decrease after chelation, we know that this one was stored at the deeper levels and is finally being pulled out of those tissues and mobilized for excretion. Thus, the higher readings are a positive sign that chelation is under way. In individuals with chronic or longstanding exposure to high amounts of heavy metal, the hair analysis readings can remain high and even go higher for a period of six to twelve months depending on the amount of previous exposure.
- Philip Hoekstra III, Ph.D., a pioneer of thermology, conducted thermological studies on six patients before they began taking the Oral Chelation and Age-Less formulas (no other supplements or medications) and then again after six months on the program. The study was conducted over the past years, under the auspices of the California Preventative Medicine Foundation in San Rafael, California.
Thermology is a diagnostic imaging based on measurements of heat emissions from the body filmed by infrared sensing devices and projected onto a computer monitor. Cells emit heat in the course of energy conversion. If there is a disturbance in the energy-conversion processes, as occurs in the case of blocked or narrowed arteries, the lessened heat emissions and reduced blood flow appear as darker areas on the thermology scan. In this way, thermology tracks the progressive deterioration of the flow of infrared energy along atherosclerotic arteries and can be used as early detection of heart disease.
The results of Dr. Hoekstra's study revealed marked improvement in blood circulation in all but one of the patients, as documented by the thermologic images. Vascularization (improved blood flow) of the feet increased by as much as 33%-significant improvements after only a six-month trial.
Nancy Gardner Heaven, director of the foundation, states, "It appears that even though the clients selected for this study had varying complex heart conditions, all but one had an improvement of at least a 20% increase in circulation, thus reducing the level of stenosis [narrowing] of the vascular system. I feel very good about recommending the use of this product [Oral Chelation and Age-Less Formulas] to my patients with cardiovascular disease or a family history where prevention is an issue."
Summaries of the Second Clinical Studies on the Oral Chelation and Age-Less Formula
· Heavy metal urine analyses were conducted on eleven (n=11) patients both before and after a single dose of the Oral Chelation and Age-Less Formula. Age ranges in this sample were from 43 to 76, and individuals were from a variety of occupations. The single Oral Chelation dose consisted of the administration of six (6) capsules prior to sleep, and the single dose Age-Less consisted of the administration of six (6) caplets upon waking in the morning. A first urine sample was collected prior to the administration of the Oral Chelation agents and a second urine sample was collected after the administration of the Age-Less agents the next day. Omegatech, King James Medical Laboratory in Cleveland, OH analyzed each of the urine samples from the 11 patients.
The results showed an increase in excretion of seven of the most toxic heavy metals most commonly encountered and damaging to health. The following are average percentage increases in heavy metal excretion in the 11 patients after just a single administration of the Oral Chelation and Age-Less Formula:
Aluminum: 182%
Arsenic: 320%
Cadmium: 9%
Copper: 344%
Lead: 162%
Mercury: 229%
Nickel: 43%
· Four patients had blood analyzed to determine the difference in total blood cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol, and blood triglyceride levels before and after the Oral Chelation protocol. Blood was drawn prior to the initiation of the Oral Chelation protocol and again eight months later. Each patient administered three (3) capsules of Oral Chelation prior to sleep and three (3) caplets of Age-Less upon waking for an eight month time period. Unilab in San Jose, CA analyzed the blood samples. The results show significant reductions in total blood cholesterol and triglyceride levels. The following are the average differences in blood composition from the initiation (baseline) of the protocol until its end at eight months. Negative values indicate a decrease in the respective constituent after the eight month time period. All values reported are in mg/dl.Total Cholesterol: -32.5 Triglycerides: -71 HDL: -0.5
LDL: -24 VLDL: -8.05 HDL/Total Cholesterol: -0.82
The following are the average changes in blood composition as percentages for the above values:Total Cholesterol: -16% Triglycerides: -29% HDL: -1%
LDL: -18% VLDL: -16% HDL/Total Cholesterol: -15%All categories, except HDL Cholesterol, significantly improved during this eight-month period. Each of these patients had cardiac problems prior to beginning our Oral Chelation eight-month protocol. All had either received, or had recommended by their physician, a form of cardiac surgery in an attempt to improve their respective conditions.
Oral Chelation and Age-Less Formula(Product Overview)
Benefits of EDTA Chelation Therapy in Arteriosclerosis a Retrospective Study of 470 Patients
by C. Hancke, MD, and K. Flytlie, MD
A Pilot Double Blind Study of Sodium Magnesium EDTA in Peripherral Vascular Disease
by Efrain Olszewer, MD, Fuad Calil Sabbag, MD, and James P. Carter, MD, DrPH New Orleans, Louisiana
EDTA Chelation Therapy Efficacy in Arteriosclerotic Heart Disease
by H. Richard Casdorph, MD, PhD
EDTA Chelation Therapy III Treatment of Peripheral Arterial Occlusion an Alternative to Amputation
by H. Richard Casdorph, MD, PhD and Charles H. Farr, MD, PhD
EDTA Chelation Therapy in Chronic Degenerative Disease
by EFRAIN OLSZEWER and JAMES P. CARTER
The Correlation Between EDTA Chelation Therapy and Improvement in Cardiovascular Function A Meta Analysis
by L. Terry Chappell, MD, and John P. Stahl, PhD
Children with Lead Poisoning
by John A, Friedman, MD, Howard L. Weinberger, MD
A Nonsurgical Approach to Obstructive Carotid Stenosis Using EDTA Chelation
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and R.K. Barber, BS, ACSM, ETT
An Observation of the Effect of EDTA Chelation and Supportive Multivitamin Trace Mineral Supplementation on Blood Platelet Volume a Brief Communication
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and R.K. Barber, BS, ACSM, ETT
An Oculocerebrovasculometric Analysis of the Improvement in Arterial Stenosis Following EDTA Chelation Therapy
by E.W. McDonagh, DO, FACGP, C.J. Rudolph, DO, PhD, E. Cheraskin, MD, DMD
Beneficial Effects of Zinc Supplementation During Chelation Treatment of Lead Intoxication in Rats
by S.J.S. Flora and S.K. Tandon
Carotid Restenosis a Case for EDTA Chelation
by H. Joseph Holliday, MD, FACA, RVT
Chelation Therapy a Survey of Treatment Outcomes and Selected SocioMedical Factors
by Wesley J. Adams, PhD, and Charles T. McGee, MD
Chelation Therapy of Occlusive Arteriosclerosis in Diabetic Patients
by Carlos P. Lamar, MD, F.I.C.A.
Chronic Diseases A Practical Method for the Reduction of Plasma Cholesterol in Man
by Henry A. Schroeder, M.D.
Current Status of EDTA Chelation Therapy in Occlusive Arterial Disease
by Elmer M. Cranton, MD, James P. Frackelton, MD
Demographic Data and Treatment of Small Companion Animals With Lead Poisoning 347 Cases 1977 to 1986
by Rhea V. Morgan, DVM; Laurie K. Pearce, DVM; Frances M. Moore, DVM; Thomas Rossi, DVM, MS
Disappearance of Immune Deposits with EDTA Chelation Therapy in a Case of IgA Nephropathy
by Ja-Liang Lin, MD
Disintergration of Retroviruses by Chelating Agents
by V. Wunderlich and G. Sydow
EDTA Chelation Treatment for Vascular Disease A Meta Analysis Using Unpublished Data
by L. Terry Chappell, MD, John P. Stahl, PhD, and Ronald Evans, MA
Effect of EDTA Chelation and Supportive Multivitamin Trace Mineral Supplementation Chronic Lung Disorders A Study of FVC and FEV
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and Rhonda.K. Barber, BS, ACSM, ETT
Effect of EDTA Chelation and Supportive Multivitamin Trace Mineral Supplementation on Carotid Circulation Case Report
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP
Effect of EDTA Chelation Therrapy Plus Multivitamintrace Mineral Supplementation Upon Vascular Dynamics Ankle Brachial Doppler Systolic Blood Pressure Ratio
by E.W. McDonagh, DO, C.J. Rudolph, DO, E Cheaskin, MD, DMD
Elevated Lead Levels in a Patient with Sickle Cell Disease and Inappropriate Secretion of Antidiuretic Hormone
by Carlos R. Suarez, MD, Lehman E. Black III, MD, R. Morrison Hurley, MD
Lead Nephropathy Gout and Hypertension
by Vicihi Batuman, MD, FACP
Lead Toxicity Chelation Therapy New Findings
by R. Gooneratne and A. Olkowski
Magnetic Resonance Imaging Evidence of a Reduction in Disc Herniation Using a Combination of EDTA Chelation and Joint Reconstructive Therapy
by C.J. Rudolph, DO, PhD, FACAM, E.W. McDonagh, DO, ACGP, FACAM
Mineral Excretion Associated with EDTA Chelation Therapy
by Hugh D. Riordan, M.D., Emanuel Cheraskin, M.D., D.M.D., and Marvin Dirks, B.D., M.A.
Visual Field Evidence of Macular Degeneration Reversal Using a Combination of EDTA Chelation and Multiple Vitamin and Trace Mineral Therapy
by C.J. Rudolph, DO, PhD, FACAM, R.T. Samuels, OD, and E.W. McDonagh, DO, ACGP, FACAM
Oral calcium EDTA in lead intoxication of children
by J. Edmund Bradley, M.D., and Albert M. Powell, Jr., M.D.
Potential Uses of Chelation Methods in the Treatment of Cardiovascular Diseases
by J. Roderick Kitchell, Lawrence E. Meltzer and Marvin J. Seven
Reduction of Elevated Plasma Lipid Levels in Artherosclerosis following EDTA Therapy
by J. H. Olwin and J. L. Koppel
Safety Evalutation Studies of Calcium EDTA
by Bernard L. Oser, Mona Oser and Howard C. Spencer
The "Clinical Change" in Patients Treated with EDTA Chelation Plus Multivitamin/Trace Mineral Supplementation
by Edward W. McDonagh, D.O., Charles J. Rudolph, Ph.D., D.O., and Emanuel Cheaskin, M.D., D.M.D.
The Correlation Between EDTA Chelation Therapy and Improvement in Cardiovascular Function: A Meta-Analysis
by L. Terry Chappell, MD, and John P. Stahl, PhD
The Current Status of EDTA Chelation Therapy
by Elmer M. Cranton, MD
The Effect of Calcium Chelation on Cardiac Arrythmias and Conduction Disturbances
by Sidney Jick, M.D. and Robert Karsh, M.D.
The Effect of EDTA Chelation Therapy Plus Supportive Multivitamin Trace Mineral Supplementation Upon Renal Function: A Study in Blood Urea Nitrogen (BUN)
by E.W. McDonagh, DO, C.J. Rudolph, DO, PhD, E. Cheraskin, MD, DMD
The Effect of EDTA Chelation Therapy Plus Supportive Multivitamin Trace Mineral Supplementation Upon Renal Function: A Study in Serum Creatinine
by EW McDonagh, DO, CJ Rudolph, PhD, DO, E Cheraskin, MD, DMD
The Effects of Thiamin on Lead Metabolism: Whole Body Retention of Lead-203
by Jin Suk Kim, Donald L. Hamilton, Barry R, Blakley, and Colin G. Rousseaux
The Efficacy of Chelation Therapy and Factors Influencing Mortality in Lead Intoxicated Petrol Sniffers
by C. B. Burns PhD, B. Currie
Treatment of Occlusive Vascular Disease with Disodium Ethylene Diamine Tetraacetic Acid (EDTA)
by Norman E. Clarke, Sr. M.D., Norman E. Clarke Jr. M.D. and Robert E. Mosher, PhD
We welcome your questions be they by phone or email.
Your health is a vitally important and we are happy to answer your questions about oral chelation and its advantages for you.
Please don't hesitate to contact us at
1-800-800-1285 Monday to Friday 9:00AM to 5:00 PM Pacific Standard Time
925-939-8006
Fax 925-988-80132175 N. California Blvd, Suite 150,
Walnut Creek, California
USA
94596
Order the highest quality:
Oral Chelation Formula
Liver Support Formula
DigestiveSupport Formula
Recommend This Site To Someone You Love
Pharmaceutical Quality, FDA approved manufacturing plant and procedures
Act Now For Your Health!
Privacy
Extreme Health takes your personal privacy seriously. Because we value our customer relationship with you, we do not sell customer information or share it with organizations.
Thank you for choosing Extreme Health. We appreciate your business.
______________________________________________________________________
Disclaimer:These statements have not been evaluated by the Food and Drug Administration. this product is not intended to diagnose, cure, treat or prevent any disease.
All information on this site is provided for informational purposes only! By no means is any information presented herein intended to substitute for the advice provided to you by your own physician or health care provider. You should not use any information contained in our site to self-diagnose or personally treat any medical condition or disease or prescribe any medication. If you have or suspect you have a medical condition you are urged to contact your personal health care provider immediately. All health supplements or products purchased in this site contain clearly labeled product packaging, which must be read to ensure proper use. All information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure or prevent any disease.
